Biotechnology VALUE FUND L P, 10% Owner at INFINITY PHARMACEUTICALS, INC. (INFI), sold 11,697,040 shares at $4.14 ($48.4M) on 2021-01-22, disclosed to the SEC on 2021-01-26.
Open-market sale of $48.4M INFI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 568,019 | $2.4M | 4.9% |
| 2 | $4.14 | 568,019 | $2.4M | 4.9% |
| 3 | $4.14 | 2,458,838 | $10.2M | 21.0% |
| 4 | $4.14 | 2,458,838 | $10.2M | 21.0% |
| 5 | $4.14 | 2,821,663 | $11.7M | 24.1% |
| 6 | $4.14 | 2,821,663 |
| $11.7M |
| 24.1% |
| Total | $4.14 avg | 11,697,040 | $48.4M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-24 | $141K | — | Filing → |
| OLMA | BUY | 2021-12-02 | $13.9M | — | Filing → |
| KYMR | BUY | 2021-07-06 | $25.6M | — | Filing → |